You just read:

New data showed OFEV® (nintedanib) slows decline of lung function in broad range of chronic fibrosing interstitial lung diseases with a progressive phenotype(1)

News provided by

Boehringer Ingelheim (Canada) Ltd.

Oct 09, 2019, 08:00 ET